We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
-9.07%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
AUM
$178M
AUM Growth
-$77.9M
Cap. Flow
-$57.1M
Cap. Flow %
-32.02%
Top 10 Hldgs %
66.72%
Holding
227
New
12
Increased
150
Reduced
51
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 38.44%
2 Technology 6.76%
3 Consumer Staples 6.63%
4 Consumer Discretionary 5.1%
5 Utilities 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EA icon
76
Electronic Arts
EA
$53B
$310K 0.17%
2,546
-111
-4% -$14.2K
MTCH icon
77
Match Group
MTCH
$9.19B
$310K 0.17%
4,451
+777
+21% +$63K
RL icon
78
Ralph Lauren
RL
$22.6B
$306K 0.17%
3,410
+387
+13% +$39K
WMB icon
79
Williams Companies
WMB
$87.5B
$305K 0.17%
9,761
-432
-4% -$14.9K
NEM icon
80
Newmont
NEM
$98.7B
$303K 0.17%
5,085
+857
+20% +$60.6K
NKE icon
81
Nike
NKE
$61.9B
$303K 0.17%
2,964
+973
+49% +$115K
KMI icon
82
Kinder Morgan
KMI
$71.7B
$300K 0.17%
17,886
-81
-0.5% -$1.52K
UHS icon
83
Universal Health Services
UHS
$10.2B
$299K 0.17%
2,968
+810
+38% +$101K
SYF icon
84
Synchrony
SYF
$24.7B
$298K 0.17%
10,805
+1,526
+16% +$53K
NUE icon
85
Nucor
NUE
$58.6B
$295K 0.17%
2,830
+424
+18% +$57.4K
PVH icon
86
PVH
PVH
$4B
$295K 0.17%
5,187
+705
+16% +$48.7K
OKE icon
87
Oneok
OKE
$57.2B
$292K 0.16%
5,255
+333
+7% +$21.6K
HCA icon
88
HCA Healthcare
HCA
$87.2B
$291K 0.16%
1,734
+515
+42% +$111K
CNC icon
89
Centene
CNC
$30.7B
$290K 0.16%
3,424
+305
+10% +$25.3K
UNH icon
90
UnitedHealth
UNH
$376B
$288K 0.16%
561
+23
+4% +$11.6K
HUM icon
91
Humana
HUM
$43.7B
$286K 0.16%
610
-1
-0.2% -$445
BKR icon
92
Baker Hughes
BKR
$60B
$279K 0.16%
9,659
+1,022
+12% +$34.6K
MOH icon
93
Molina Healthcare
MOH
$10.2B
$275K 0.15%
982
+151
+18% +$45.6K
ELV icon
94
Elevance Health
ELV
$81.5B
$272K 0.15%
564
+4
+0.7% +$1.98K
MNST icon
95
Monster Beverage
MNST
$94.3B
$272K 0.15%
5,858
-4,132
-41% -$180K
BBWI icon
96
Bath & Body Works
BBWI
$4.06B
$271K 0.15%
10,056
+3,111
+45% +$135K
MRNA icon
97
Moderna
MRNA
$21.8B
$270K 0.15%
1,889
+227
+14% +$32.4K
TAP icon
98
Molson Coors Class B
TAP
$7.79B
$266K 0.15%
4,887
+89
+2% +$4.78K
VRTX icon
99
Vertex Pharmaceuticals
VRTX
$121B
$266K 0.15%
945
-27
-3% -$7.23K
HAL icon
100
Halliburton
HAL
$26.9B
$264K 0.15%
8,404
-287
-3% -$10.7K

Similar funds

Vantage Consulting Group's Q2 2022 Portfolio in Review

As of Q2 2022, Vantage Consulting Group held 227 positions worth $178M, down 30% from $256M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Vantage Consulting Group withdrew a net $57.1M in Q2 2022, closing 14 positions and reducing 51 holdings. Its most notable exit was NXP Semiconductors, an estimated $270K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 57% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Vantage Consulting Group opened a new position in Keurig Dr Pepper worth $255K.

  • Vantage Consulting Group's largest Q2 2022 buy was Keurig Dr Pepper: 7,196 shares worth $255K.
  • Vantage Consulting Group added most to Syntax Stratified LargeCap ETF in Q2 2022, an estimated $10.4M increase.
  • Vantage Consulting Group's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $68.7M.
  • Vantage Consulting Group fully exited NXP Semiconductors in Q2 2022, selling an estimated $270K.
  • Vantage Consulting Group's ten largest holdings make up 67% of its $178M portfolio in Q2 2022.
  • Vantage Consulting Group opened 12 new positions and closed 14 in Q2 2022.
  • Vantage Consulting Group's portfolio value fell 30% quarter-over-quarter to $178M.

Based on Vantage Consulting Group's 13F filing for Q2 2022, filed 9 Aug 2022.